Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 5, 2006, Pages 1155-1162

  Thivierge, Maryse ^a   Stankova, Jana ^a   Rola Pleszczynski, Marek ^a  

^a Faculty of Medicine   (Canada)

Author keywords

allergy; dendritic cells; Human; inflammation; leukotriene; lipid mediators

Indexed keywords

CALCIUM; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOTRIENE; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONTELUKAST; PEPTIDOLEUKOTRIENE; PEPTIDOLEUKOTRIENE RECEPTOR 1; PEPTIDOLEUKOTRIENE RECEPTOR 2; POLYINOSINIC POLYCYTIDYLIC ACID; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 3 AGONIST; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 4 AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOSOL; DENDRITIC CELL; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM;

CALCIUM; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYSTEINE; DENDRITIC CELLS; HUMANS; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENES; MEMBRANE PROTEINS; RECEPTORS, LEUKOTRIENE; TOLL-LIKE RECEPTORS;

EID: 33646136460     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.12.1342     Document Type: Article

References (35)

1. Steinman R. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 9 (1991) 271-296
2. Hart D.N. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90 (1997) 3245-3287
3. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
4. Sallusto F., Cella M., Danieli C., and Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182 (1995) 389-400
5. Mellman I., and Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 106 (2001) 255-258
6. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188 (1998) 373-386
7. Sallusto F., and Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 177 (2000) 134-140
8. Sallusto F., and Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 189 (1999) 611-614
9. Randolph G.J., Beaulieu S., Pope M., Sugawara I., Hoffman L., Steinman R.M., et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci U S A 95 (1998) 6924-6929
10. Robbiani D.F., Finch R.A., Jager D., Muller W.A., Sartorelli A.C., and Randolph G.J. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103 (2000) 757-768
11. Wijnholds J., Evers R., van Leusden M.R., Mol C.A., Zaman G.J., Mayer U., et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 3 (1997) 1275-1279
12. Machida I., Matsuse H., Kondo Y., Kawano T., Saeki S., Tomari S., et al. Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma. J Immunol 172 (2004) 1833-1838
13. Lynch K.R., O'Neill G.P., Liu Q., Im D.S., Sawyer N., Metters K.M., et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399 (1999) 789-793
14. Sarau H.M., Ames R.S., Chambers J., Ellis C., Elshourbagy N., Foley J.J., et al. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol 56 (1999) 657-663
15. Heise C.E., O'Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T., Im D.S., et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 275 (2000) 30531-30536
16. Figueroa D.J., Breyer R.M., Defoe S.K., Kargman S., Daugherty B.L., Waldburger K., et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 163 (2001) 226-233
17. Thivierge M., Le Gouill C., Tremblay M.J., Stankova J., and Rola-Pleszczynski M. Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate. Blood 92 (1998) 40-45
18. Thivierge M., Stankova J., and Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol 167 (2001) 2855-2860
19. Murakami M., Penrose J.F., Urade Y., Austen K.F., and Arm J.P. Interleukin 4 suppresses c-kit ligand-induced expression of cytosolic phospholipase A2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells. Proc Natl Acad Sci U S A 92 (1995) 6107-6111
20. Mehindate K., al-Daccak R., Aoudjit F., Damdoumi F., Fortier M., Borgeat P., et al. Interleukin-4, transforming growth factor beta 1, and dexamethasone inhibit superantigen-induced prostaglandin E2-dependent collagenase gene expression through their action on cyclooxygenase-2 and cytosolic phospholipase A2. Lab Invest 75 (1996) 529-538
21. Spanbroek R., Hildner M., Kohler A., Muller A., Zintl F., Kuhn H., et al. IL-4 determines eicosanoid formation in dendritic cells by down-regulation of 5-lipoxygenase and up-regulation of 15-lipoxygenase 1 expression. Proc Natl Acad Sci U S A 98 (2001) 5152-5157
22. Mohamadzadeh M., Berard F., Essert G., Chalouni C., Pulendran B., Davoust J., et al. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J Exp Med 194 (2001) 1013-1020
23. Okunishi K., Dohi M., Nakagome K., Tanaka R., and Yamamoto K. A novel role of cysteinyl leukotrienes to promote dendritic cell activation in the antigen-induced immune responses in the lung. J Immunol 173 (2004) 6393-6402
24. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
25. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
26. Sabroe I., Read R.C., Whyte M.K., Dockrell D.H., Vogel S.N., and Dower S.K. Toll-like receptors in health and disease: complex questions remain. J Immunol 171 (2003) 1630-1635
27. Iwaki D., Mitsuzawa H., Murakami S., Sano H., Konishi M., Akino T., et al. The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus. J Biol Chem 277 (2002) 24315-24320
28. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 (2001) 732-738
29. Takeuchi O., Kaufmann A., Grote K., Kawai T., Hoshino K., Morr M., et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 164 (2000) 554-557
30. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11 (1999) 443-451
31. Sato S., Nomura F., Kawai T., Takeuchi O., Muhlradt P.F., Takeda K., et al. Synergy and cross-tolerance between Toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol 165 (2000) 7096-7101
32. Yang H., Young D.W., Gusovsky F., and Chow J.C. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 275 (2000) 20861-20866
33. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
34. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., et al. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol 3 (2002) 392-398
35. Re F., and Strominger J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 276 (2001) 37692-37699